BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32541138)

  • 21. Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.
    Yagasaki H; Nakane T; Hasebe Y; Watanabe A; Kise H; Toda T; Koizumi K; Hoshiai M; Sugita K
    Am J Med Genet A; 2015 Dec; 167A(12):3144-7. PubMed ID: 26286251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IDH1-R132 changes vary according to NPM1 and other mutations status in AML.
    Falini B; Spinelli O; Meggendorfer M; Martelli MP; Bigerna B; Ascani S; Stein H; Rambaldi A; Haferlach T
    Leukemia; 2019 Apr; 33(4):1043-1047. PubMed ID: 30622284
    [No Abstract]   [Full Text] [Related]  

  • 23. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Novel Functional Variants of SIN3A and SRSF1 among Somatic Variants in Acute Myeloid Leukemia Patients.
    Min JW; Koh Y; Kim DY; Kim HL; Han JA; Jung YJ; Yoon SS; Choi SS
    Mol Cells; 2018 May; 41(5):465-475. PubMed ID: 29764005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.
    Dong L; Yu WM; Zheng H; Loh ML; Bunting ST; Pauly M; Huang G; Zhou M; Broxmeyer HE; Scadden DT; Qu CK
    Nature; 2016 Nov; 539(7628):304-308. PubMed ID: 27783593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome.
    Karow A; Steinemann D; Göhring G; Hasle H; Greiner J; Harila-Saari A; Flotho C; Zenker M; Schlegelberger B; Niemeyer CM; Kratz CP
    Leukemia; 2007 Jun; 21(6):1303-5. PubMed ID: 17361219
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.
    Walker A; Marcucci G
    Expert Rev Hematol; 2012 Oct; 5(5):547-58. PubMed ID: 23146058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells.
    Xu D; Liu X; Yu WM; Meyerson HJ; Guo C; Gerson SL; Qu CK
    J Exp Med; 2011 Sep; 208(10):1977-88. PubMed ID: 21930766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noonan syndrome patients beyond the obvious phenotype: A potential unfavorable metabolic profile.
    Noronha RM; Villares SMF; Torres N; Quedas EPS; Homma TK; Albuquerque EVA; Moraes MB; Funari MFA; Bertola DR; Jorge AAL; Malaquias AC
    Am J Med Genet A; 2021 Mar; 185(3):774-780. PubMed ID: 33382187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
    Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
    J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noonan syndrome: Severe phenotype and PTPN11 mutations.
    Carrasco Salas P; Gómez-Molina G; Carreto-Alba P; Granell-Escobar R; Vázquez-Rico I; León-Justel A
    Med Clin (Barc); 2019 Jan; 152(2):62-64. PubMed ID: 29703613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid leukemia patients.
    Elsayed GM; Nassar HR; Zaher A; Elnoshokaty EH; Moneer MM
    J Egypt Natl Canc Inst; 2014 Mar; 26(1):43-9. PubMed ID: 24565682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient juvenile myelomonocytic leukemia in the setting of PTPN11 mutation and Noonan syndrome with secondary development of monosomy 7.
    O'Halloran K; Ritchey AK; Djokic M; Friehling E
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28084675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
    Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
    BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of the PTPN11 gene in Egyptian patients with Noonan syndrome.
    Essawi ML; Ismail MF; Afifi HH; Kobesiy MM; El Kotoury A; Barakat MM
    J Formos Med Assoc; 2013 Nov; 112(11):707-12. PubMed ID: 24183200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noonan and LEOPARD syndrome Shp2 variants induce heart displacement defects in zebrafish.
    Bonetti M; Paardekooper Overman J; Tessadori F; Noël E; Bakkers J; den Hertog J
    Development; 2014 May; 141(9):1961-70. PubMed ID: 24718990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.
    Herold T; Metzeler KH; Vosberg S; Hartmann L; Jurinovic V; Opatz S; Konstandin NP; Schneider S; Zellmeier E; Ksienzyk B; Graf A; Krebs S; Blum H; Cristina Sauerland M; Büchner T; Berdel WE; Wörmann BJ; Mansmann U; Hiddemann W; Bohlander SK; Spiekermann K; Greif PA
    Genes Chromosomes Cancer; 2017 Jan; 56(1):75-86. PubMed ID: 27636548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
    Roberts AE; Araki T; Swanson KD; Montgomery KT; Schiripo TA; Joshi VA; Li L; Yassin Y; Tamburino AM; Neel BG; Kucherlapati RS
    Nat Genet; 2007 Jan; 39(1):70-4. PubMed ID: 17143285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome.
    Pannone L; Bocchinfuso G; Flex E; Rossi C; Baldassarre G; Lissewski C; Pantaleoni F; Consoli F; Lepri F; Magliozzi M; Anselmi M; Delle Vigne S; Sorge G; Karaer K; Cuturilo G; Sartorio A; Tinschert S; Accadia M; Digilio MC; Zampino G; De Luca A; Cavé H; Zenker M; Gelb BD; Dallapiccola B; Stella L; Ferrero GB; Martinelli S; Tartaglia M
    Hum Mutat; 2017 Apr; 38(4):451-459. PubMed ID: 28074573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory failure, juvenile myelomonocytic leukemia, and neonatal Noonan syndrome.
    Cheong JL; Moorkamp MH
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):262-4. PubMed ID: 17414570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.